- Home
- ADUS vs SLNO Comparison
ADUS vs SLNO Comparison
Compare ADUS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADUS
- SLNO
- Stock Information
- Founded
- ADUS 1979
- SLNO 1999
- Country
- ADUS United States
- SLNO United States
- Employees
- ADUS N/A
- SLNO N/A
- Industry
- ADUS Medical/Nursing Services
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ADUS Health Care
- SLNO Health Care
- Exchange
- ADUS Nasdaq
- SLNO Nasdaq
- Market Cap
- ADUS 2.1B
- SLNO 3.8B
- IPO Year
- ADUS 2009
- SLNO 2014
- Fundamental
- Price
- ADUS $114.62
- SLNO $86.14
- Analyst Decision
- ADUS Buy
- SLNO Strong Buy
- Analyst Count
- ADUS 10
- SLNO 9
- Target Price
- ADUS $143.50
- SLNO $103.33
- AVG Volume (30 Days)
- ADUS 166.2K
- SLNO 1.0M
- Earning Date
- ADUS 08-04-2025
- SLNO 08-06-2025
- Dividend Yield
- ADUS N/A
- SLNO N/A
- EPS Growth
- ADUS 9.84
- SLNO N/A
- EPS
- ADUS 4.42
- SLNO N/A
- Revenue
- ADUS $1,211,561,000.00
- SLNO N/A
- Revenue This Year
- ADUS $23.16
- SLNO N/A
- Revenue Next Year
- ADUS $5.77
- SLNO N/A
- P/E Ratio
- ADUS $26.26
- SLNO N/A
- Revenue Growth
- ADUS 11.38
- SLNO N/A
- 52 Week Low
- ADUS $88.96
- SLNO $39.41
- 52 Week High
- ADUS $136.72
- SLNO $86.79
- Technical
- Relative Strength Index (RSI)
- ADUS 57.98
- SLNO 62.72
- Support Level
- ADUS $112.37
- SLNO $78.48
- Resistance Level
- ADUS $115.16
- SLNO $86.67
- Average True Range (ATR)
- ADUS 3.07
- SLNO 2.78
- MACD
- ADUS -0.27
- SLNO 0.40
- Stochastic Oscillator
- ADUS 63.86
- SLNO 67.95
About ADUS Addus HomeCare Corporation
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.